Invention Grant
- Patent Title: Pyrazine compounds as phosphodiesterase 10 inhibitors
- Patent Title (中): 吡嗪化合物作为磷酸二酯酶10抑制剂
-
Application No.: US12619574Application Date: 2009-11-16
-
Publication No.: US08053438B2Publication Date: 2011-11-08
- Inventor: Jennifer R. Allen , Matthew P. Bourbeau , Ning Chen , Essa Hu , Roxanne Kunz
- Applicant: Jennifer R. Allen , Matthew P. Bourbeau , Ning Chen , Essa Hu , Roxanne Kunz
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Elsa D. Lemoine
- Main IPC: A61K31/4965
- IPC: A61K31/4965

Abstract:
Pyrazine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.
Public/Granted literature
- US20100137278A1 PYRAZINE COMPOUNDS AS PHOSPHODIESTERASE 10 INHIBITORS Public/Granted day:2010-06-03
Information query